CryoStasis

CryoStasis Inc. is a biotechnology company based in Ottawa, Canada, focused on advanced bio-preservation technologies for cells, tissues, and organs. The company specializes in solutions for organ transplantation and cell/gene therapy products. Their proprietary Subzero Unfrozen (SU) cryopreservation platform preserves biological materials at subzero temperatures without freezing, ensuring optimal cell viability and function. The Woolii™ SU preservation solution combines unique media, temperature, and pressure systems to enable indefinite preservation of biological materials. This includes cold shock inhibitors and membrane protectants to prevent cryoinjury. CryoStasis also provides temperature control devices and shipping solutions that maintain the viability of preserved cells, facilitating integration into manufacturing and logistics workflows. Their technology supports critical applications in organ transplantation and the growing field of cell and gene therapies, positioning CryoStasis as a key player in cold chain management and preservation. Led by CEO Keith Millar, CryoStasis draws on over 30 years of research and development in bio-preservation, aiming to address challenges in healthcare and biotechnology.

• Employees 14
• Founded 2022